Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > RBC New Target Price - $64 USD
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Health123on Mar 28, 2016 1:11pm
116 Views
Post# 24704993

RE:RE:RE:RBC New Target Price - $64 USD

RE:RE:RE:RBC New Target Price - $64 USDAdamchess, Royal Bank Capital holds a large portion of Concordia's credit facility so their targets are expected to be on the higher end.  You should do your own DD and phone Douglas Meihm and actually ask him how many of RBC Funds hold CXR/CXRX shares
His number is 416-842-7823.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities